Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details)

v3.3.1.900
Commitments and Contingencies (Details)
$ in Millions
 1 Months Ended 12 Months Ended
Jul. 31, 2012
claim
Dec. 31, 2015
USD ($)
shares
Dec. 31, 2014
USD ($)
Business Acquisition, Contingent Consideration [Line Items]      
Contingent consideration   $ 54.4 $ 71.6
Issuance of common stock | shares   1,194,337  
Number of claims included in post-payment audit | claim 183    
Fixed purchase provisions   $ 48.3  
Accrued Expenses      
Business Acquisition, Contingent Consideration [Line Items]      
Contingent consideration   22.2 27.4
Other Long-term Liabilities      
Business Acquisition, Contingent Consideration [Line Items]      
Contingent consideration   32.3 $ 44.2
OPKO Renal      
Business Acquisition, Contingent Consideration [Line Items]      
Payments on loss contingency   $ 20.0